MED

SEC source: 0001628280-23-028943 · wk-form4_1691703409.xml · nonDerivative · entry 3

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,725.295

F5 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-028939 · wk-form4_1691703313.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,764.477

Underlying: Common Stock · 36.643 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-028942 · wk-form4_1691703382.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,485.061

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-028941 · wk-form4_1691703353.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,202.736

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-028938 · wk-form4_1691703279.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,325.709

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-028943 · wk-form4_1691703409.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey Brown Living Trust

Disclosed balance after: 4,136.231

F3 · shares: These shares were acquired by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F4 · ownership.nature: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.

SEC source: 0001628280-23-028943 · wk-form4_1691703409.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 38,316.638

F1 · shares: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F2 · ownership.nature: These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.

SEC source: 0001628280-23-025514 · wk-form4_1690248243.xml · nonDerivative · entry 3

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,752

SEC source: 0001628280-23-025514 · wk-form4_1690248243.xml · nonDerivative · entry 2

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,779

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: 1,787 Performance Stock Units were granted on July 20, 2020, and vested on July 20, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors.

SEC source: 0001628280-23-025514 · wk-form4_1690248243.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,205

SEC source: 0001628280-23-022810 · wk-form4_1687307849.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,727.834

Underlying: Common Stock · 2,742 shares

Expires not disclosed

F1 · derivative.exercise_price: Represents the contingent right to receive 2,742 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.exercise_date: Represents the contingent right to receive 2,742 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

F1 · derivative.expiration_date: Represents the contingent right to receive 2,742 shares of the Issuer's common stock or the cash equivalent in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated) (the "Deferred Compensation Plan"). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024. The restricted stock units will become payable in cash upon or following the reporting person's termination of service as a director of the Issuer pursuant to the terms of the Deferred Compensation Plan.

SEC source: 0001628280-23-022803 · wk-form4_1687307496.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,164.621

F1 · shares: Represents the right to receive 3,118 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.

SEC source: 0001628280-23-022802 · wk-form4_1687307451.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,445.237

F1 · shares: Represents the right to receive 3,152 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.

SEC source: 0001628280-23-022798 · wk-form4_1687307341.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,288.065

F1 · shares: Represents the right to receive 3,118 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.

SEC source: 0001628280-23-022797 · wk-form4_1687307279.xml · nonDerivative · entry 1

Geary Elizabeth A. · CIK 0001981550 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,781

F1 · shares: Represents the right to receive 1,781 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.

SEC source: 0001628280-23-022795 · wk-form4_1687307223.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,681.154

F1 · shares: Represents the right to receive 3,289 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 15, 2024.

SEC source: 0001628280-23-017667 · wf-form4_168384135788085.xml · nonDerivative · entry 3

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,392.154

F5 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-017666 · wf-form4_168384133975264.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,170.065

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-017665 · wf-form4_168384131656450.xml · nonDerivative · entry 1

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,590.853

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-017664 · wf-form4_168384128978669.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,046.621

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-017663 · wf-form4_168384127527001.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,293.237

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-017662 · wf-form4_168384125726827.xml · derivative · entry 1

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,985.834

Underlying: Common Stock · 12.379 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-017667 · wf-form4_168384135788085.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Jeffrey Brown Living Trust

Disclosed balance after: 4,069.112

F3 · shares: These shares were acquired by the Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F4 · ownership.nature: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.

SEC source: 0001628280-23-017667 · wf-form4_168384135788085.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 37,694.873

F1 · shares: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F2 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC , for which the reporting person is the managing member.

SEC source: 0001628280-23-014353 · wf-form4_168294536658185.xml · nonDerivative · entry 2

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,496

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-23-014351 · wf-form4_168294527313368.xml · nonDerivative · entry 3

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,320

F1 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-23-014351 · wf-form4_168294527313368.xml · nonDerivative · entry 2

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,746

SEC source: 0001628280-23-014348 · wf-form4_168294494677956.xml · nonDerivative · entry 5

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,128

F2 · shares: Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001628280-23-014348 · wf-form4_168294494677956.xml · nonDerivative · entry 4

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,321

SEC source: 0001628280-23-014353 · wf-form4_168294536658185.xml · nonDerivative · entry 1

MacKenzie Jonathan Barrett · CIK 0001883230 · VP, Finance & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 590

SEC source: 0001628280-23-014351 · wf-form4_168294527313368.xml · nonDerivative · entry 1

Maloney James P. · CIK 0001715428 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,821

SEC source: 0001628280-23-014348 · wf-form4_168294494677956.xml · nonDerivative · entry 3

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,193

SEC source: 0001628280-23-007912 · wf-form4_167883173575226.xml · derivative · entry 3

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,300

Underlying: Common Stock · 2,200 shares

Expires 2026-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The reporting person received 5,000 stock options on February 4, 2016 pursuant to the Medifast, Inc. Amended and Restated 2012 Share Incentive Plan. These options vested in three equal annual installments beginning on February 4, 2017.

SEC source: 0001628280-23-007912 · wf-form4_167883173575226.xml · nonDerivative · entry 2

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,280.092

SEC source: 0001628280-23-007912 · wf-form4_167883173575226.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,480.092

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001628280-23-014348 · wf-form4_168294494677956.xml · nonDerivative · entry 2

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,551

F1 · price: 17,038 Performance Stock Units were granted on February 19, 2020, and vested on December 31, 2022 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 24, 2023 and the shares were released on March 7, 2023.

SEC source: 0001628280-23-014348 · wf-form4_168294494677956.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,194

F1 · price: 17,038 Performance Stock Units were granted on February 19, 2020, and vested on December 31, 2022 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 24, 2023 and the shares were released on March 7, 2023.

SEC source: 0001628280-23-004667 · wf-form4_167712105139871.xml · nonDerivative · entry 1

Chard Daniel R · CIK 0001289557 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,118

F1 · shares: These shares were withheld to satisfy the tax withholding obligations upon vesting of an equity award.

F2 · price: This equity award vested on February 19, 2023, which fell on a weekend. The price used for the withholding was the closing sales price for the most recent trading day prior to the vesting date.

SEC source: 0001628280-23-003055 · wf-form4_167599477045468.xml · derivative · entry 2

Xian Ming · CIK 0001743879 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,973.454

Underlying: Common Stock · 9.232 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F2 · kind: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

F1 · derivative.exercise_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

F1 · derivative.expiration_date: Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.

SEC source: 0001628280-23-003054 · wf-form4_167599472726883.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,377.123

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-003050 · wf-form4_167599465954281.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,280.092

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-003053 · wf-form4_167599469653536.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,157.293

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-003051 · wf-form4_167599467705263.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,033.672

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-003049 · wf-form4_167599464004476.xml · nonDerivative · entry 1

HALLQUIST CONSTANCE J. · CIK 0001645615 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,577.51

F1 · shares: Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-23-003054 · wf-form4_167599472726883.xml · nonDerivative · entry 3

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Jeffrey Brown Living Trust

Disclosed balance after: 3,995.65

F4 · shares: The shares were acquired by the Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F5 · ownership.nature: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.

SEC source: 0001628280-23-003054 · wf-form4_167599472726883.xml · nonDerivative · entry 2

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Brown Equity Partners, LLC

Disclosed balance after: 37,014.343

F2 · shares: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F3 · ownership.nature: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member.

SEC source: 0001628280-22-029564 · wf-form4_166812321065156.xml · nonDerivative · entry 1

BROWN JEFFREY J · CIK 0001245377 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,365.912

F1 · kind: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-22-029563 · wf-form4_166812318826575.xml · nonDerivative · entry 1

Thomas Andrea B · CIK 0001779769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,024.015

F1 · shares: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-22-029561 · wf-form4_166812313629031.xml · nonDerivative · entry 1

Hoer Michael A. · CIK 0001743755 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,147.768

F1 · shares: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.

SEC source: 0001628280-22-029562 · wf-form4_166812316325297.xml · nonDerivative · entry 1

SCHLACKMAN SCOTT · CIK 0001645617 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,270.288

F1 · shares: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.